Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 14, 2006
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
281/15/10337    most recent
M512009200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by English, J. L.
Right arrow Articles by Khokha, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by English, J. L.
Right arrow Articles by Khokha, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print February 9, 2006
J. Biol. Chem, 10.1074/jbc.M512009200
Submitted on November 8, 2005
Revised on February 7, 2006
Accepted on February 9, 2006

Individual timp deficiencies differentially impact pro-MMP-2 activaiton

Jane L. English, Zamaneh Kassiri, Ilpo Koskivirta, Susan J. Atkinson, Marco Di Grappa, Paul D. Soloway, Hideaki Nagase, Eero Vuorio, Gillian Murphy, and Rama Khokha

Onatrio Cancer Institute, Room# 10-330, Toronto, Ontario M5G 2M9

Corresponding Author: rkhokha{at}uhnres.utoronto.ca

Membrane-type matrix metalloproteinases (MT-MMPs) have emerged as key enzymes in tumour cell biology. The importance of MT1-MMP in particular, is highlighted by its ability to activate pro-MMP-2 at the cell surface through the formation of a trimolecular complex comprised of MT1-MMP/tissue inhibitor of metalloproteinase-2 (TIMP-2)/pro-MMP-2. TIMPs 1-4 are physiological MMP inhibitors with distinct roles in the regulation of pro-MMP-2 processing. Here, we show that individual timp-deficiencies differentially affect MMP-2 processing using primary mouse embryonic fibroblasts (MEFs). Timp-3 deficiency accelerated pro-MMP-2 activation in response to both cytochalasin D and concanavalin A. Exogenous TIMP-2 and N-TIMP-3 inhibited this activation, whereas TIMP-3 containing matrix from wild type (WT) MEFs did not rescue the enhanced MMP-2 activation in Timp-3-/- cells. Increased processing of MMP-2 did not arise from increased expression of MT1-MMP, MT2-MMP or MT3-MMP, or altered expression of TIMP-2 and MMP-2. To test whether increased MMP-2 processing in Timp-3-/- MEFs is dependent on TIMP-2, double deficient Timp-2-/-/-3-/- cells were used. In these double deficient cells, the cleavage of pro-MMP-2 to its intermediate form was substantially increased, but the subsequent cleavage of intermediate-MMP-2 to fully active, while absent in Timp-2-/- MEFs, was detectable with combined Timp-2-/-/-3-/- deficiency. TIMP-4 associates with MMP-2 and MT1-MMP in a manner similar to TIMP-3, but its deletion had no effect on pro-MMP-2 processing. Thus, TIMP-3 provides an inherent regulation over the kinetics of pro-MMP-2 processing, serving at a level distinct from that of TIMP-2 and TIMP-4.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
G. Gabriely, T. Wurdinger, S. Kesari, C. C. Esau, J. Burchard, P. S. Linsley, and A. M. Krichevsky
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Mol. Cell. Biol., September 1, 2008; 28(17): 5369 - 5380.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Johnson, G. B. Sala-Newby, Y. Ismail, C. M. Aguilera, and A. C. Newby
Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages
Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1647 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Chen, J. K. McGuire, R. C. Hackman, K.-H. Kim, R. A. Black, K. Poindexter, W. Yan, P. Liu, A. J. Chen, W. C. Parks, et al.
Tissue Inhibitor of Metalloproteinase-1 Moderates Airway Re-Epithelialization by Regulating Matrilysin Activity
Am. J. Pathol., May 1, 2008; 172(5): 1256 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Sun, C. R. Weber, A. Sohail, M. M. Bernardo, M. Toth, H. Zhao, J. R. Turner, and R. Fridman
MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties
J. Biol. Chem., July 27, 2007; 282(30): 21998 - 22010.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement